Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21.

Bocharnikov AV, Keegan J, Wacleche VS, Cao Y, Fonseka CY, Wang G, Muise ES, Zhang KX, Arazi A, Keras G, Li ZJ, Qu Y, Gurish MF, Petri M, Buyon JP, Putterman C, Wofsy D, James JA, Guthridge JM, Diamond B, Anolik JH, Mackey MF, Alves SE, Nigrovic PA, Costenbader KH, Brenner MB, Lederer JA, Rao DA; Accelerating Medicines Partnership (AMP) RA/SLE Network.

JCI Insight. 2019 Oct 17;4(20). pii: 130062. doi: 10.1172/jci.insight.130062.

2.

Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene.

Demma MJ, Mapelli C, Sun A, Bodea S, Ruprecht B, Javaid S, Wiswell D, Muise E, Chen S, Zelina J, Orvieto F, Santoprete A, Altezza S, Tucci F, Escandon E, Hall B, Ray K, Walji A, O'Neil J.

Mol Cell Biol. 2019 Oct 28;39(22). pii: e00248-19. doi: 10.1128/MCB.00248-19. Print 2019 Nov 15.

3.

Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D acute myeloid leukaemia model.

Xu H, Muise ES, Javaid S, Chen L, Cristescu R, Mansueto MS, Follmer N, Cho J, Kerr K, Altura R, Machacek M, Nicholson B, Addona G, Kariv I, Chen H.

J Cell Mol Med. 2019 Oct;23(10):7063-7077. doi: 10.1111/jcmm.14608. Epub 2019 Aug 26.

4.

BET Bromodomain Inhibition Suppresses Human T Cell Function.

Georgiev P, Wang Y, Muise ES, Bandi ML, Blumenschein W, Sathe M, Pinheiro EM, Shumway SD.

Immunohorizons. 2019 Jul 11;3(7):294-305. doi: 10.4049/immunohorizons.1900037.

PMID:
31356159
5.

PAN-AMPK Activation Improves Renal Function in a Rat Model of Progressive Diabetic Nephropathy.

Zhou X, Muise ES, Haimbach R, Sebhat IK, Zhu Y, Liu F, Souza SC, Kan Y, Pinto S, Kelley DE, Hoek M.

J Pharmacol Exp Ther. 2019 Oct;371(1):45-55. doi: 10.1124/jpet.119.258244. Epub 2019 Jul 12.

PMID:
31300612
6.

Pharmacological AMPK activation induces transcriptional responses congruent to exercise in skeletal and cardiac muscle, adipose tissues and liver.

Muise ES, Guan HP, Liu J, Nawrocki AR, Yang X, Wang C, Rodríguez CG, Zhou D, Gorski JN, Kurtz MM, Feng D, Leavitt KJ, Wei L, Wilkening RR, Apgar JM, Xu S, Lu K, Feng W, Li Y, He H, Previs SF, Shen X, van Heek M, Souza SC, Rosenbach MJ, Biftu T, Erion MD, Kelley DE, Kemp DM, Myers RW, Sebhat IK.

PLoS One. 2019 Feb 27;14(2):e0211568. doi: 10.1371/journal.pone.0211568. eCollection 2019.

7.

Potentiation of serotonin signaling protects against intestinal ischemia and reperfusion injury in mice.

Tackett JJ, Gandotra N, Bamdad MC, Muise ED, Cowles RA.

Neurogastroenterol Motil. 2019 Mar;31(3):e13498. doi: 10.1111/nmo.13498. Epub 2018 Nov 4.

PMID:
30394002
8.

GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy.

Satapati S, Qian Y, Wu MS, Petrov A, Dai G, Wang SP, Zhu Y, Shen X, Muise ES, Chen Y, Zycband E, Weinglass A, Di Salvo J, Debenham JS, Cox JM, Lan P, Shah V, Previs SF, Erion M, Kelley DE, Wang L, Howard AD, Shang J.

J Lipid Res. 2017 Aug;58(8):1561-1578. doi: 10.1194/jlr.M075044. Epub 2017 Jun 5.

9.

Localization of muscarinic acetylcholine receptor 2 to the intestinal crypt stem cell compartment.

Muise ED, Gandotra N, Tackett JJ, Bamdad MC, Cowles RA.

Data Brief. 2016 Dec 21;10:482-486. doi: 10.1016/j.dib.2016.12.032. eCollection 2017 Feb.

10.

Enhanced serotonin signaling stimulates ordered intestinal mucosal growth.

Tackett JJ, Gandotra N, Bamdad MC, Muise ED, Cowles RA.

J Surg Res. 2017 Feb;208:198-203. doi: 10.1016/j.jss.2016.09.036. Epub 2016 Sep 28.

PMID:
27993209
11.

Accurate assessment of bowel length: the method of measurement matters.

Muise ED, Tackett JJ, Callender KA, Gandotra N, Bamdad MC, Cowles RA.

J Surg Res. 2016 Nov;206(1):146-150. doi: 10.1016/j.jss.2016.07.022. Epub 2016 Jul 18.

PMID:
27916354
12.

Distribution of muscarinic acetylcholine receptor subtypes in the murine small intestine.

Muise ED, Gandotra N, Tackett JJ, Bamdad MC, Cowles RA.

Life Sci. 2017 Jan 15;169:6-10. doi: 10.1016/j.lfs.2016.10.030. Epub 2016 Nov 17.

PMID:
27866962
13.

A comparison of suction and full-thickness rectal biopsy in children.

Muise ED, Hardee S, Morotti RA, Cowles RA.

J Surg Res. 2016 Mar;201(1):149-55. doi: 10.1016/j.jss.2015.10.031. Epub 2015 Oct 28.

PMID:
26850196
14.

Rectal biopsy for Hirschsprung's disease: a review of techniques, pathology, and complications.

Muise ED, Cowles RA.

World J Pediatr. 2016 May;12(2):135-41. doi: 10.1007/s12519-015-0068-5. Epub 2015 Dec 18. Review.

PMID:
26684314
15.

Effects of Long-Term Odanacatib Treatment on Bone Gene Expression in Ovariectomized Adult Rhesus Monkeys: Differentiation From Alendronate.

Muise ES, Podtelezhnikov AA, Pickarski M, Loboda A, Tan Y, Hu G, Thomspon JR, Duong le T.

J Bone Miner Res. 2016 Apr;31(4):839-51. doi: 10.1002/jbmr.2752. Epub 2016 Jan 8.

16.

Gene expression in WAT from healthy humans and monkeys correlates with FGF21-induced browning of WAT in mice.

Schlessinger K, Li W, Tan Y, Liu F, Souza SC, Tozzo E, Liu K, Thompson JR, Wang L, Muise ES.

Obesity (Silver Spring). 2015 Sep;23(9):1818-29. doi: 10.1002/oby.21153.

17.

Transition of care in pediatric surgical patients with complex gastrointestinal disease.

Muise ED, Cowles RA.

Semin Pediatr Surg. 2015 Apr;24(2):65-8. doi: 10.1053/j.sempedsurg.2015.01.002. Epub 2015 Jan 9. Review.

PMID:
25770365
18.

Malrotation: Current strategies navigating the radiologic diagnosis of a surgical emergency.

Tackett JJ, Muise ED, Cowles RA.

World J Radiol. 2014 Sep 28;6(9):730-6. doi: 10.4329/wjr.v6.i9.730. Review.

19.

Identification and characterization of sebaceous gland atrophy-sparing DGAT1 inhibitors.

Muise ES, Zhu Y, Verras A, Karanam BV, Gorski J, Weingarth D, Lin HV, Hwa J, Thompson JR, Hu G, Liu J, He S, DeVita RJ, Shen DM, Pinto S.

PLoS One. 2014 Feb 18;9(2):e88908. doi: 10.1371/journal.pone.0088908. eCollection 2014.

20.

Downstream signaling pathways in mouse adipose tissues following acute in vivo administration of fibroblast growth factor 21.

Muise ES, Souza S, Chi A, Tan Y, Zhao X, Liu F, Dallas-Yang Q, Wu M, Sarr T, Zhu L, Guo H, Li Z, Li W, Hu W, Jiang G, Paweletz CP, Hendrickson RC, Thompson JR, Mu J, Berger JP, Mehmet H.

PLoS One. 2013 Sep 6;8(9):e73011. doi: 10.1371/journal.pone.0073011. eCollection 2013.

21.

Anti-diabetic efficacy and impact on amino acid metabolism of GRA1, a novel small-molecule glucagon receptor antagonist.

Mu J, Qureshi SA, Brady EJ, Muise ES, Candelore MR, Jiang G, Li Z, Wu MS, Yang X, Dallas-Yang Q, Miller C, Xiong Y, Langdon RB, Parmee ER, Zhang BB.

PLoS One. 2012;7(11):e49572. doi: 10.1371/journal.pone.0049572. Epub 2012 Nov 19.

22.

Novel transcriptome profiling analyses demonstrate that selective peroxisome proliferator-activated receptor γ (PPARγ) modulators display attenuated and selective gene regulatory activity in comparison with PPARγ full agonists.

Tan Y, Muise ES, Dai H, Raubertas R, Wong KK, Thompson GM, Wood HB, Meinke PT, Lum PY, Thompson JR, Berger JP.

Mol Pharmacol. 2012 Jul;82(1):68-79. doi: 10.1124/mol.111.076679. Epub 2012 Apr 10.

PMID:
22496518
23.

SirT1 regulates adipose tissue inflammation.

Gillum MP, Kotas ME, Erion DM, Kursawe R, Chatterjee P, Nead KT, Muise ES, Hsiao JJ, Frederick DW, Yonemitsu S, Banks AS, Qiang L, Bhanot S, Olefsky JM, Sears DD, Caprio S, Shulman GI.

Diabetes. 2011 Dec;60(12):3235-45. doi: 10.2337/db11-0616.

24.

Enhanced fatty acid flux triggered by adiponectin overexpression.

Shetty S, Ramos-Roman MA, Cho YR, Brown J, Plutzky J, Muise ES, Horton JD, Scherer PE, Parks EJ.

Endocrinology. 2012 Jan;153(1):113-22. doi: 10.1210/en.2011-1339. Epub 2011 Nov 1.

25.

Genome-wide expression profiling revealed peripheral effects of cannabinoid receptor 1 inverse agonists in improving insulin sensitivity and metabolic parameters.

Zhao W, Fong O, Muise ES, Thompson JR, Weingarth D, Qian S, Fong TM.

Mol Pharmacol. 2010 Sep;78(3):350-9. doi: 10.1124/mol.110.064980. Epub 2010 Jun 7.

PMID:
20530130
26.

Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma and extracellular fluid volume.

Acton JJ 3rd, Akiyama TE, Chang CH, Colwell L, Debenham S, Doebber T, Einstein M, Liu K, McCann ME, Moller DE, Muise ES, Tan Y, Thompson JR, Wong KK, Wu M, Xu L, Meinke PT, Berger JP, Wood HB.

J Med Chem. 2009 Jul 9;52(13):3846-54. doi: 10.1021/jm900097m. Erratum in: J Med Chem. 2013 Nov 27;56(22):9368. Tan, Yugen [corrected to Tan, Yejun].

PMID:
19507861
27.

Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo.

Landskroner-Eiger S, Qian B, Muise ES, Nawrocki AR, Berger JP, Fine EJ, Koba W, Deng Y, Pollard JW, Scherer PE.

Clin Cancer Res. 2009 May 15;15(10):3265-76. doi: 10.1158/1078-0432.CCR-08-2649. Epub 2009 May 15.

28.

Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI.

Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N, Zhang BB, Bonaldo P, Chua S, Scherer PE.

Mol Cell Biol. 2009 Mar;29(6):1575-91. doi: 10.1128/MCB.01300-08. Epub 2008 Dec 29.

29.

Optimization and structure-activity relationship of a series of 1-phenyl-1,8-naphthyridin-4-one-3-carboxamides: identification of MK-0873, a potent and effective PDE4 inhibitor.

Guay D, Boulet L, Friesen RW, Girard M, Hamel P, Huang Z, Laliberté F, Laliberté S, Mancini JA, Muise E, Pon D, Styhler A.

Bioorg Med Chem Lett. 2008 Oct 15;18(20):5554-8. doi: 10.1016/j.bmcl.2008.09.009. Epub 2008 Sep 6.

PMID:
18835163
30.

Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states.

Muise ES, Azzolina B, Kuo DW, El-Sherbeini M, Tan Y, Yuan X, Mu J, Thompson JR, Berger JP, Wong KK.

Mol Pharmacol. 2008 Aug;74(2):403-12. doi: 10.1124/mol.108.044826. Epub 2008 May 8.

PMID:
18467542
31.

A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.

Chang CH, McNamara LA, Wu MS, Muise ES, Tan Y, Wood HB, Meinke PT, Thompson JR, Doebber TW, Berger JP, McCann ME.

Eur J Pharmacol. 2008 Apr 14;584(1):192-201. doi: 10.1016/j.ejphar.2007.12.036. Epub 2008 Feb 14.

PMID:
18346728
32.

Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitor.

Macdonald D, Mastracchio A, Perrier H, Dubé D, Gallant M, Lacombe P, Deschênes D, Roy B, Scheigetz J, Bateman K, Li C, Trimble LA, Day S, Chauret N, Nicoll-Griffith DA, Silva JM, Huang Z, Laliberté F, Liu S, Ethier D, Pon D, Muise E, Boulet L, Chan CC, Styhler A, Charleson S, Mancini J, Masson P, Claveau D, Nicholson D, Turner M, Young RN, Girard Y.

Bioorg Med Chem Lett. 2005 Dec 1;15(23):5241-6. Epub 2005 Sep 15.

PMID:
16168647
33.

Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinity.

Friesen RW, Ducharme Y, Ball RG, Blouin M, Boulet L, Côté B, Frenette R, Girard M, Guay D, Huang Z, Jones TR, Laliberté F, Lynch JJ, Mancini J, Martins E, Masson P, Muise E, Pon DJ, Siegl PK, Styhler A, Tsou NN, Turner MJ, Young RN, Girard Y.

J Med Chem. 2003 Jun 5;46(12):2413-26.

PMID:
12773045
34.

Comparison of inhibition of ovalbumin-induced bronchoconstriction in guinea pigs and in vitro inhibition of tumor necrosis factor-alpha formation with phosphodiesterase 4 (PDE4) selective inhibitors.

Muise ES, Chute IC, Claveau D, Masson P, Boulet L, Tkalec L, Pon DJ, Girard Y, Frenette R, Mancini JA.

Biochem Pharmacol. 2002 Apr 15;63(8):1527-35.

PMID:
11996895
35.

Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey.

Lamontagne S, Meadows E, Luk P, Normandin D, Muise E, Boulet L, Pon DJ, Robichaud A, Robertson GS, Metters KM, Nantel F.

Brain Res. 2001 Nov 30;920(1-2):84-96.

PMID:
11716814
36.

Promoter analysis of the murine T-cell protein tyrosine phosphatase gene.

Wee C, Muise ES, Coquelet O, Ennis M, Wagner J, Lemieux N, Branton PE, Nepveu A, Tremblay ML.

Gene. 1999 Sep 17;237(2):351-60.

PMID:
10521659
37.

Characterization of CHO-K1 cells stably expressing PDE-IV enzymes. Whole-cell cAMP determinations vs broken-cell enzymatic assays.

Pon DJ, Plant M, Tkach J, Boulet L, Muise E, Allen RA, Rodger IW.

Cell Biochem Biophys. 1998;29(1-2):159-78.

PMID:
9631244
38.

Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice.

You-Ten KE, Muise ES, Itié A, Michaliszyn E, Wagner J, Jothy S, Lapp WS, Tremblay ML.

J Exp Med. 1997 Aug 29;186(5):683-93.

39.

High-resolution linkage map in the proximity of the host resistance locus Cmv1.

Depatie C, Muise E, Lepage P, Gros P, Vidal SM.

Genomics. 1997 Jan 15;39(2):154-63.

PMID:
9027502
40.

Thermosensitive mutants of the MPTP and hPTP1B protein tyrosine phosphatases: isolation and structural analysis.

Muise ES, Vrielink A, Ennis MA, Lemieux NH, Tremblay ML.

Protein Sci. 1996 Apr;5(4):604-13.

41.

Structure of the murine MPTP-PEST gene: genomic organization and chromosomal mapping.

Charest A, Wagner J, Muise ES, Heng HH, Tremblay ML.

Genomics. 1995 Aug 10;28(3):501-7.

PMID:
7490087

Supplemental Content

Support Center